by Michael Roub | Oct 29, 2026 | Healthcare, M&A Strategy
The email lands on a regular Tuesday. A buyer has been watching your practice, admires what you built, and wants to talk about an acquisition. The number they float sounds big. The tone feels both urgent and flattering. That moment reads like validation. It...
by Michael Roub | Oct 27, 2026 | Healthcare, M&A Strategy
Most healthcare deals do not die over price. They stall in due diligence when a buyer’s accountants start pulling your earnings apart and find numbers that don’t hold up. That moment delays a close, triggers a price cut, or ends the deal. Buyers scrutinize...
by Michael Roub | Oct 21, 2026 | Healthcare, M&A Strategy
Running a full-schedule practice and preparing one to sell are two separate jobs. The first keeps your team paid and your chairs busy. The second builds something a buyer will pay a premium to own. Most dentists spend decades on the first and a few frantic weeks on...
by Michael Roub | Oct 12, 2026 | Healthcare, M&A Strategy
If you own a medical practice, your inbox and voicemail are likely stacked with outreach from management services organizations. They promise capital, support, a path to scale. But behind that steady stream of interest sits a harder question: who controls your...
by Michael Roub | Oct 2, 2026 | Healthcare
The deal closes, the wire hits, and the real work starts. In the weeks after an acquisition, value can slip away faster than most buyers expect. The purchase agreement does not lock in the people, patients, and relationships you paid for. They stay, or they leave...
